PRESBIA PLC (NASDAQ:LENS) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
Presbia PLC (the Company) intends, from time to time, to present
and/or distribute to the investment community and utilize at
various industry and investor conferences a slide
presentation.The slide presentation is attached hereto as Exhibit
99.1.
In accordance with General Instruction B.2 of Form 8-K, the
information in this Item 7.01 of this Current Report on Form 8-K,
including Exhibit 99.1, shall not be deemed filed for the
purposes of Section 18 of the Securities and Exchange Act of
1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Exchange Act or the
Securities Act of 1933, as amended, except as expressly set forth
by reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Number |
Exhibit |
|
99.1 |
Investor Presentation (furnished herewith) |
About PRESBIA PLC (NASDAQ:LENS)
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders. PRESBIA PLC (NASDAQ:LENS) Recent Trading Information
PRESBIA PLC (NASDAQ:LENS) closed its last trading session up +0.02 at 2.62 with 23,202 shares trading hands.
